Vaxart Inc (VXRT)
0.9275
-0.03
(-3.26%)
USD |
NASDAQ |
May 20, 09:43
Vaxart Accounts Receivable (Quarterly): 0.556M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.556M |
December 31, 2023 | 3.008M |
September 30, 2023 | 0.424M |
June 30, 2023 | 0.029M |
March 31, 2023 | 0.264M |
December 31, 2022 | 0.02M |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.081M |
December 31, 2021 | 0.071M |
September 30, 2021 | 0.19M |
June 30, 2021 | 0.107M |
March 31, 2021 | 0.70M |
December 31, 2020 | 0.334M |
September 30, 2020 | 0.25M |
June 30, 2020 | 0.227M |
March 31, 2020 | 2.663M |
December 31, 2019 | 3.619M |
September 30, 2019 | 0.559M |
June 30, 2019 | 0.035M |
March 31, 2019 | 5.584M |
December 31, 2018 | 1.796M |
September 30, 2018 | 0.174M |
June 30, 2018 | 0.205M |
March 31, 2018 | 12.17M |
Date | Value |
---|---|
December 31, 2017 | 2.50M |
September 30, 2017 | 0.10M |
June 30, 2017 | 0.60M |
March 31, 2017 | 6.60M |
December 31, 2016 | 4.20M |
September 30, 2016 | 0.60M |
June 30, 2016 | 0.70M |
March 31, 2016 | 10.10M |
December 31, 2015 | 5.10M |
September 30, 2015 | 3.20M |
June 30, 2015 | 12.60M |
March 31, 2015 | 10.10M |
December 31, 2014 | 7.00M |
September 30, 2014 | 0.50M |
June 30, 2014 | 0.90M |
March 31, 2014 | 36.50M |
December 31, 2013 | 26.90M |
September 30, 2013 | 12.90M |
June 30, 2013 | 0.10M |
March 31, 2013 | 15.17M |
December 31, 2012 | 11.38M |
September 30, 2012 | |
June 30, 2012 | 0.00 |
March 31, 2012 | |
December 31, 2011 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2022
3.619M
Maximum
Dec 2019
0.6568M
Average
0.2385M
Median
Accounts Receivable (Quarterly) Benchmarks
Novavax Inc | 21.38M |
Allogene Therapeutics Inc | -- |
Inovio Pharmaceuticals Inc | -- |
Stereotaxis Inc | 3.953M |
Capricor Therapeutics Inc | 0.369M |